New Research Confirms the Benefit of Extended-Release Dipyridamole
Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk
Aggrenox® (Asasantin® Retard) considered by many as
first-line in secondary stroke prevention
INGELHEIM, Germany, 31 May 2007 - New data presented today at the
16th European Stroke Conference in Glasgow confirm that therapy
with dipyridamole plus ASA
(extended-release dipyridamole plus...
AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
...with a three-fold higher risk of major CV events,(4A) which can occur within just 1-2 weeks of discontinuation.(4B) Up to 1 in 3 patients on low-dose asa
may develop upper GI symptoms.(5A,6A)
AstraZeneca conducted two studies to evaluate the safety and efficacy of NEXIUM in reducing the risk of gas...
Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer
...haradin to Treat Bone Metastases
in Major Cancer Indications
(OSE: ALGETA), the cancer therapeutics company, announces that
with the res...ick on the ALSYPMCA link in the menu bar.
is a cancer therapeutics company built on world-leading,
Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
...rate Test's Potential for Rapid Uptake
OSLO and FOSTER CITY, California, November 10 /PRNewswire-FirstCall/ --
(OSL: DIAG) and Applied Biosystems Inc. (NYSE: ABI ) today
announced the launch of BCtect(TM), a blood-based test for early detection
of breast cance...
Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting
... after the surgery. Therefore, modulating
temperature becomes a very important tool in the physician's armamentarium.
The cases being presented at the asa
underscore the utility of temperature
management for these situations."
Various factors contribute to hypothermia during surgery, including the
Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
...urvival of Patients
With Hormone Refractory Prostate Cancer (HRPC)
(OSE: ALGETA), the Norwegian cancer therapeutics company,
today announced t... Research and the Royal Marsden Hospital in
is a Norwegian cancer therapeutics company built on
Michael J. Fox Foundation Funds $1.1 Million for Cutting-Edge Approaches to Parkinson's Disease Under Rapid Response Innovation Awards 2008
... provided the head of their
lab serves as administrative PI.
Among the potentially high-impact Rapid Response projects funded so far
Abeliovich, MD, PhD, of Columbia University is working to
determine whether a gene silencing technique using microRNAs -- short,
noncoding molecules o...
Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
...patients, with an average antiplatelet therapy duration of 12.5 days.
After NCS, thienopyridine administration was not restarted and 100 mg per
day of asa
was the only cardiac antiplatelet therapy at discharge. MACE,
including in-hospital cardiac death, MI, stent thrombosis, surgical
Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
...reversible neurological damage. MLD is caused by a deficiency
in the enzyme asa
which causes an excess concentration of sulphatide in
cells and an ensuing ...tely 2,000 MLD
patients in developed world markets(1).
The newly acquired asa
product, currently known as METAZYM(TM), has
completed a Phase Ib clinical ...
Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
...under of GeoVax Labs, Inc. She served as Chief of Microbiology and
Immunology at Emory University's Yerkes National Primate Research Center
and was an asa
Griggs Candler Professor of Microbiology and Immunology at
the Emory University School of Medicine.
Dr. Robinson is a pioneer in DNA vaccines and on...
Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
...e Japan, Plavix(R) has shown favourable tolerability
profile as compared to asa
and an acceptable increase in major bleedings
when used in combination with asa
(no statistical difference when only PCIs
are considered). In Japan, Plavi...
Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia
...review by the EMEA was announced on July 20,
2007. The anticipated submissions for the U.S. and Japan are on schedule
for later this year. During this asa
annual meeting results from four
additional Phase III trials were presented. About Organon Organon creates, manufactures and markets innovative pres...
MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study
of Aquavan Injection in Patients Undergoing Bronchoscopy
...rate was 86.7% compared to 25.5% among patients
treated with an initial bolus control dose of 2.0 mg/kg of Aquavan
(p less than 0.001). Based upon the asa
Classification System, 31% of patients in this study were
classified as P1 (having no known systemic disease), 65% were
classified as ...
Viral Enzyme Recruited in Fight Against Ear Infection
...Fischetti. "This might truly be
a case in which an ounce of prevention would be worth a pound of
Other St. Jude authors of this paper include asa
Amy R. Iverson (St. Jude).
This work was supported in part by the United States Public
Health Service and ALSAC.
St. Jude Children's...
Algeta to Present Phase II Clinical Study Data for Alpharadin in
Prostate Cancer at ASCO
... OSLO, Norway, 30 May 2007 - Algeta asa
(OSE: ALGETA), the
Norwegian cancer therapeutics company, announces that Pr...firstname.lastname@example.org
Citigate Dewe Rogerson
(www.algeta.com ) is a No...
Algeta Demonstrates Targeted Cancer-killing Potential of Novel
Alpha Particle Linked Antibodies in Leading Medical Journal Blood...an 90Y-tiuxetan-ibritumomab
OSLO, Norway, 14 June 2007 - Algeta asa (OSE: ALGETA), the
Norwegian cancer therapeutics company, announces that a ...email@example.com
Citigate Dewe Rogerson
Algeta asa (www.algeta.com ) is a No...